Will AstraZeneca’s 3 types of antibody be transferred to ‘Alvogen’?

AstraZeneca’s 3 types of antibody are expected to be transferred to Alvogen.

According to the industry concerned on the 26^th, the two companies are discussing license transfers of 3 current breast cancer therapies, such as ‘Nolvadex(tamoxifen),’ ‘Arimidex(anastrozole)’ and ‘Faslodex(fulvestrant).’ 

However, whether all their licenses will be transferred and when the transfers will be made hav...